Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Brain Neoplasms 2Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma 1Leukemia 1Hematologic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Cyclophosphamide 7Specimen Handling 5fludarabine 4Standard of Care 4trametinib 3Practice Guidelines as Topic 3Magnetic Resonance Spectroscopy 3GSK2636771 3Biopsy 3venetoclax 2talquetamab 2osimertinib 2dabrafenib 2capivasertib 2binimetinib 2X-Rays 2Thiotepa 2Tacrolimus 2Patient Navigation 2Nivolumab 2Mycophenolic Acid 2Methods 2Mesna 2Melphalan 2Filgrastim 2Educational Status 2Early Intervention, Educational 2Crizotinib 2Ado-Trastuzumab Emtansine 22-(3-(2-(1-isopropyl-3-methyl-1H-1,2-4-triazol-5-yl)-5,6-dihydrobenzo(f)imidazo(1,2-d)(1,4)oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hematologic Neoplasms × Mental Status and Dementia Tests × 30 days × Clear all
NCT05011045 2026-05-20

Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies

M.D. Anderson Cancer Center

Recruiting
100 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡